Towards a Smart Blood Culture Bottle: Machine Learning Assisted Electrochemical Profiling to Provide Early In-situ Identification of Bloodstream Infections Pathogens
Sponsor: University Hospital, Grenoble
Trial Details
| Condition | Bacteremia Sepsis |
| Intervention | Blood culture sampling |
| Phase | NA |
| Status | Recruiting |
| Participants | 200 |
| Est. Completion | 1 Jan 2028 |
| Last Updated | 22 July 2026 |
Primary Outcome
List of samples with an electrochemical profile
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * patient requiring a blood culture sample as standard of care procedure * body weight \> 50 Kg * Patient for whom the collection of 2 to 4 additional blood culture bottles is feasible, depending on venous access * patient who has not objected to participation in the project Exclusion Criteria: * Patient protected under the French Public Health Code (pregnant or breastfeeding women, patients under guardianship or curatorship, hospitalized under constraint, or deprived of liberty) * patients with ongoing antibiotic treatment at the time of sampling
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service